MBX
NASDAQ · Pharmaceuticals
Mbx Biosciences Inc
$52.48
-2.52 (-4.58%)
Open$55.95
Previous Close$55.00
Day High$57.00
Day Low$51.73
52W High$72.64
52W Low$17.93
Volume—
Avg Volume542.4K
Market Cap2.69B
P/E Ratio—
EPS$-2.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-10.2% upside
Current
$52.48
$52.48
Target
$47.13
$47.13
$32.34
$47.13 avg
$55.83
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 515.19M | 454.58M | 572.08M |
| Net Income | 92.27M | 88.31M | 111.14M |
| Profit Margin | 17.9% | 19.4% | 19.4% |
| EBITDA | 143.26M | 124.50M | 146.54M |
| Free Cash Flow | 88.64M | 54.29M | 70.53M |
| Rev Growth | +6.8% | +2.6% | +10.2% |
| Debt/Equity | 1.22 | 1.24 | 1.00 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |